Recent News for LMNX - Luminex Corporation

Date Title
Oct 4 Luminex (LMNX) Presents At Cantor Healthcare Conference - Slideshow
Oct 4 Is Luminex Corporation's (NASDAQ:LMNX) CEO Salary Justified?
Oct 3 Luminex Gets FDA Nod for ARIES MRSA Assay, Boosts Platform
Oct 1 FDA clears Luminex's ARIES MRSA Assay
Oct 1 Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay
Sep 27 Goldman sees 38% upside in Seattle Genetics in premarket analyst action
Sep 26 Luminex Corporation to Present at the Cantor Global Healthcare Conference on October 2, 2019
Sep 4 Do Insiders Own Lots Of Shares In Luminex Corporation (NASDAQ:LMNX)?
Sep 3 Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
Aug 27 Luminex Corp (LMNX) President & CEO Nachum Shamir Bought $98,550 of Shares
Aug 3 Edited Transcript of LMNX earnings conference call or presentation 31-Jul-19 8:30pm GMT
Aug 1 Luminex (LMNX) Reports Q2 Loss, Beats Revenue Estimates
Aug 1 Luminex Corporation's (LMNX) CEO Homi Shamir on Q2 2019 Results - Earnings Call Transcript
Aug 1 Luminex Corp (DE) (LMNX) Q2 2019 Earnings Call Transcript
Jul 31 Luminex declares $0.09 dividend
Jul 31 Luminex EPS misses by $0.10, beats on revenue
Jul 31 Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend
Jul 30 Luminex Q2 2019 Earnings Preview
Jul 30 Notable earnings after Wednesday’s close
Jul 26 If You Had Bought Luminex (NASDAQ:LMNX) Stock A Year Ago, You'd Be Sitting On A 39% Loss, Today
Jul 24 Earnings Preview: Luminex (LMNX) Q2 Earnings Expected to Decline
Jul 18 Verigene II, Amnis, And Guava Will Reposition Luminex
Jul 11 Luminex Corporation Second Quarter Earnings Release Scheduled for July 31, 2019
Jul 3 Luminex (LMNX) Presents ARIES MRSA Assay to FDA for Clearance
Jul 1 Luminex Submits ARIES MRSA Assay for FDA Clearance
Back to the Main LMNX Page...